ANVISA registration 10071770939Valid until Dec 11, 2033HEPATITIS B VIRUS SURFACE ANTIGEN (HBSAG)
ANVISA Registration Number: 10071770939ABBOTT DIAGNOSTICOS RAPIDOS S.A.ABON BIOPHARM (HANGZHOU) CO LTDRisk Class IV
Device names
- Technical name
- HEPATITIS B VIRUS SURFACE ANTIGEN (HBSAG)
- Commercial name
- HBsAg Hepatitis B Surface Antigen Rapid Test Device
- Risk class
- Class IV
PT: ANTÍGENO DE SUPERFÍCIE DE VÍRUS DA HEPATITE B (HBSAG)
Registration details
- Registration Number
- 10071770939
- Process Number
- 25351486679202368
- CNPJ
- 50248780000161
Company information
- Registration Holder
- ABBOTT DIAGNOSTICOS RAPIDOS S.A.
- Manufacturer
- ABON BIOPHARM (HANGZHOU) CO LTD
- Manufacturing Country
- China
PT: CHINA, REPÚBLICA POPULAR
Dates and status
- Publication Date
- Dec 11, 2023
- Validity
- 11/12/2033
- Last Updated
- 08/18/2026 19:00:00
About this record
Access comprehensive regulatory information for HEPATITIS B VIRUS SURFACE ANTIGEN (HBSAG) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 10071770939 and manufactured by ABON BIOPHARM (HANGZHOU) CO LTD. The registration is held by ABBOTT DIAGNOSTICOS RAPIDOS S.A. with validity until Dec 11, 2033.
This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.